⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

AI Visibility Scorecard

Promontory Therapeutics | Advancing small molecule immunotherapy

Promontory Therapeutics | Advancing small molecule immunotherapy

Unclaimed

phosplatin.com · Media & Entertainment

Somewhat visible. AI bots can read Promontory Therapeutics | Advancing small molecule immunotherapy, but it is missing the structured signals that push citation rate above competitors.

AI engines read this profile 4 times

Claude · ChatGPT · Meta AI

#299,135 of 1,898,195 in Media & Entertainment for AI visibility

5.7

/10

AEO Score

Share

About Promontory Therapeutics | Advancing small molecule immunotherapy

from our crawl and measurement

"Promontory Therapeutics is developing novel small molecule immunogenic anti-cancer agents. Their lead agent, PT-112, is a highly potent immunogenic cell death (ICD) inducer, currently in." That is how Promontory Therapeutics of Floor New York, NY introduces itself. To AI engines like ChatGPT and Perplexity it is partially visible, scoring 5.6 out of 10, readable in places and missing in others.

Our crawl found structured data on the page (WebSite) and a readable heading structure. It is missing an llms.txt file and a sitemap.

AI crawlers have visited 2 times in our tracking, including ClaudeBot (Anthropic).

Industry · Media & Entertainment
Last scored · Aug 8, 2026

The 6 signals AI reads

Higher is better · 0-10

Structured Data

3

Organization / LocalBusiness JSON-LD that AI can read.

Content Structure

9

Clear headings and answer-style content.

Entity Clarity

5

How clearly your brand identity reads to AI.

E-E-A-T Signals

Experience, Expertise, Authority, Trust

0

Experience, Expertise, Authority, Trust markers.

Technical AEO

6

robots.txt, llms.txt, and AI-bot crawl access.

AI Discoverability

6

Sitemaps and entity links AI can follow.

Off-page authority

How the web signals your brand to AI

Backlinks

9

Inbound links from other sites.

Domain Authority

3

Established authority for your domain.

Reference Presence

0

Not in AI knowledge graphs yet.

News & Press

0

No press coverage found yet.

Community

0

No community discussion yet.

Social Mentions

0

No social discussion found yet.

What this score means

Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 5.7/10, Promontory Therapeutics | Advancing small molecule immunotherapy has a working base to build on - fixable, and the signals above are where to start.

Is this your brand?

The exact fixes for Promontory Therapeutics | Advancing small molecule immunotherapy

Which AI engines already crawl you

Weekly ChatGPT & Claude citation tracking

Already have an account? Sign in

Picked for Promontory Therapeutics | Advancing small molecule immunotherapy: How-To

How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide

The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for Promontory Therapeutics | Advancing small molecule immunotherapy.

Source & Attribution

Scored by Engagemii on August 8, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/phosplatin

Cite this score: Engagemii (2026). "AEO Score for Promontory Therapeutics | Advancing small molecule immunotherapy." Retrieved from https://engagemii.com/aeo/brands/phosplatin

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - The Answer Engine Optimization (AEO) Platform